Published in BMC Med Imaging on August 29, 2006
Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol (2012) 1.64
Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study. J Hypertens (2008) 0.97
Relationship between left ventricular geometric pattern and systolic and diastolic function in treated Nigerian hypertensives. Cardiovasc J Afr (2010) 0.86
Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors. BMC Res Notes (2014) 0.82
Correlates of left ventricular mass in hypertensive Nigerians: an echocardiographic study. Cardiovasc J Afr (2010) 0.78
Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment. J Clin Diagn Res (2013) 0.77
Assessment of voltage criteria for left ventricular hypertrophy in adult hypertensives in south-western Nigeria. J Cardiovasc Dis Res (2013) 0.75
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition (1992) 16.89
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens (1999) 11.00
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation (1977) 9.70
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol (1999) 2.98
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens (2005) 1.79
The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med (1992) 1.67
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol (1986) 1.56
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1996) 1.24
Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens (2005) 1.23
Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol (1995) 1.21
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. Hypertension (2000) 1.20
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol (1996) 0.98
Correlates of left atrial size in Nigerian hypertensives. Cardiovasc J S Afr (2005) 0.90
Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press (2001) 0.83
Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass? J Hum Hypertens (1999) 0.79
Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives. J Hum Hypertens (2001) 0.78
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med (2012) 3.96
Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J (2008) 2.20
Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol (2012) 1.64
Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis (2006) 1.54
Left ventricular diastolic function parameters in hypertensives. J Natl Med Assoc (2005) 1.50
Hypertensive heart failure in Nigerian Africans: insights from the Abeokuta Heart Failure Registry. J Clin Hypertens (Greenwich) (2015) 1.43
Left ventricular geometric patterns in newly presenting Nigerian hypertensives: an echocardiographic study. BMC Cardiovasc Disord (2006) 1.08
Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men. Hypertension (2007) 1.00
Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa. Heart (2013) 1.00
Correlates of left atrial size in Nigerian hypertensives. Cardiovasc J S Afr (2005) 0.90
Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives. Ethn Dis (2005) 0.90
Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. Int J Cardiol (2011) 0.87
Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol (2015) 0.86
Left ventricular diastolic function in normotensive type-2 diabetic subjects. J Natl Med Assoc (2008) 0.84
Republished: recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa. Postgrad Med J (2014) 0.81
Episodic vertigo resulting from vascular risk factors, cervical spondylosis and head rotation: Two case reports. Neuropsychiatr Dis Treat (2007) 0.79
Uncorrected tetralogy of fallot in a 25-year old nigerian african. Clin Med Insights Case Rep (2011) 0.78
Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria. BMC Cardiovasc Disord (2009) 0.77
Left ventricular geometric patterns in normotensive type 2 diabetic patients in Nigeria: an echocardiographic study. Prev Cardiol (2009) 0.77
Changes in left atrial dimension and function and left ventricular geometry in newly diagnosed untreated hypertensive subjects. J Cardiovasc Med (Hagerstown) (2008) 0.76
Plasma catecholamines in Nigerians with primary hypertension. Ethn Dis (2011) 0.76
The burden of heart failure in Africa. Eur J Heart Fail (2013) 0.75
Regarding Cardiac disease patterns in northern Malawi: epidemiologic transition perspective. J Epidemiol (2009) 0.75
Prevalence and severity of atherosclerosis in extra cranial carotid arteries in Nigeria: an autopsy study. BMC Cardiovasc Disord (2012) 0.75
Getting to the heart of obesity. Eur Heart J (2005) 0.75
Non-invasive estimation of pulmonary artery pressures in patients with sickle cell anaemia in Ibadan, Nigeria: an echocardiographic study. Acta Cardiol (2014) 0.75
Characterisation of left ventricular function by tissue Doppler imaging technique in newly diagnosed, untreated hypertensive subjects. Cardiovasc J Afr (2008) 0.75
Renal dysfunction in African patients with acute heart failure. Eur J Heart Fail (2014) 0.75
Blood pressure control and left ventricular hypertrophy in hypertensive Nigerians. Ann Afr Med (2009) 0.75
Drug utilization and blood pressure control in ambulatory hypertensive patients: focus on those with compelling indications. Int J Clin Pharmacol Ther (2017) 0.75